BRIEF-Otsuka's JYNARQUE Approved By FDA As First Treatment to Slow Kidney Function Decline
April 24, 2018 at 15:25 PM EDT
* U.S. FDA APPROVED JYNARQUE AS DRUG TREATMENT TO SLOW KIDNEY FUNCTION DECLINE IN ADULTS AT RISK OF RAPIDLY PROGRESSING ADPKD Source text for Eikon: Further company coverage:
